- $26.40m
- $20.34m
- $5.91m
- 74
- 81
- 51
- 77
Annual balance sheet for Bexil, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 0.938 | 3.75 | 3.73 | 2.55 | 6.22 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.218 | 0.389 | 0.261 | 0.221 | 0.23 |
| Prepaid Expenses | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 23.1 | 23 | 27.2 | 25.5 | 28.3 |
| Payable / Accrued | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Liabilities | 1.02 | 0.121 | 0.085 | -0.021 | 1.02 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 22.1 | 22.9 | 27.1 | 25.5 | 27.3 |
| Total Liabilities & Shareholders' Equity | 23.1 | 23 | 27.2 | 25.5 | 28.3 |
| Total Common Shares Outstanding |